This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
DAY ONE WATCH LIVE (EST); 19/10/20keyboard_arrow_right

DAY ONE WATCH LIVE (EST); 19/10/20

keyboard_arrow_leftSearch & Filter
search

DAY ONE WATCH LIVE (EST); 19/10/20

search
This agenda is just the start. Wherever you are in the world, the Cell Therapy Bioprocessing & Commercialization and Cell Therapy Manufacturing & Gene Therapy Congresses are coming to you. The talks listed here are just the tip of the iceberg. Please also make sure to browse all of our 'on-demand' sessions which available to watch at your convenience.
7:25am - 7:30am5 mins
Cell Therapy
Welcome from Sarah Lintern - Conference Organizer
    7:25am - 7:30am5 mins
    Gene Edited Ex Vivo Cell Therapy
    Welcome from Sarah Lintern - Conference Organizer
      7:25am - 7:30am5 mins
      In Vivo Gene Therapy
      Welcome from Sarah Lintern - Conference Organizer
        7:25am - 7:30am5 mins
        Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
        Welcome from Sarah Lintern - Conference Organizer
          7:30am - 7:50am20 mins
          Cell Therapy
          Data Governance and Data Integrity as a framework during Process Development
          • Sara Levy - CSV & Data integrity Manager, Pluristem Therapeutics Inc.
          7:30am - 7:50am20 mins
          Gene Edited Ex Vivo Cell Therapy
          Senti Bio Case Study – Gene Edited MSc
          • Philip Lee - COO and Co-Founder, Senti Biosciences
          7:30am - 7:50am20 mins
          In Vivo Gene Therapy
          Next Generation Cell Line Development & Large-Scale Bioprocessing Technology
          • Sam Wadsworth - Chief Scientific Officer, Ultragenyx Gene Therapy
          7:30am - 7:50am20 mins
          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
          Scalable, Consistent, Cost-effective Manufacturing for Tissues and Organs
          • Mary Clare McCorry - Director, Technology and Process Development, Advanced Regenerative Manufacturing Institute (ARMI)
          7:50am - 8:15am25 mins
          Cell Therapy
          Speaker Q&A - Cell Therapy Process Development
          • Lior Raviv - Vice President, Pluristem Therapeutics Inc.
          • Sara Levy - CSV & Data integrity Manager, Pluristem Therapeutics Inc.
          • Mustafa Munye - Lead Scientist, Cell and Gene Therapy Catapult
          • Rachel Yost - Senior Process Engineer, Juno Therapeutics Inc.
          7:50am - 8:15am25 mins
          Gene Edited Ex Vivo Cell Therapy
          Speaker Q&A - Auto vs. Allo Manufacturing & Infrastructure
          • Geoffrey Hodge - Chief Technical Officer, Unum Therapeutics
          • Philip Lee - COO and Co-Founder, Senti Biosciences
          • Gregory Russotti - Chief Technology Officer, Century Therapeutics LLC, USA
          7:50am - 8:15am25 mins
          In Vivo Gene Therapy
          Speaker Q&A - High Throughput Applications in Production Platforms & Enabling Manufacturing Tech
          • Sam Wadsworth - Chief Scientific Officer, Ultragenyx Gene Therapy
          7:50am - 8:15am25 mins
          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
          The Importance of High Quality Raw Materials for Developing your Cell or Gene-Modified Cell Therapy: A Master Cell Bank Case Study
          • Benjamin Fryer - Founder, Pluristyx, Incorporated, USA
          8:15am - 9:00am45 mins
          Cell Therapy
          Coffee Break & Exhibition Viewing Time
            8:15am - 9:00am45 mins
            Gene Edited Ex Vivo Cell Therapy
            Coffee Break & Exhibition Viewing Time
              8:15am - 9:00am45 mins
              In Vivo Gene Therapy
              Coffee Break & Exhibition Viewing Time
                8:15am - 9:00am45 mins
                Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                Coffee Break & Exhibition Viewing Time
                  9:00am - 9:10am10 mins
                  Cell Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  Gene Edited Ex Vivo Cell Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  In Vivo Gene Therapy
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:00am - 9:10am10 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Opening Remarks from the Chairperson
                  • Miguel Forte - CEO, Bone Therapeutics, Belgium
                  9:10am - 10:00am50 mins
                  Cell Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - Head of Operations, Sentien Biotechnologies Inc.
                  • Camilo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis - Co-Founder & CEO, Aegis BioDefense Inc., USA
                  9:10am - 10:00am50 mins
                  Gene Edited Ex Vivo Cell Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - Head of Operations, Sentien Biotechnologies Inc.
                  • Camilo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis - Co-Founder & CEO, Aegis BioDefense Inc., USA
                  9:10am - 10:00am50 mins
                  In Vivo Gene Therapy
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - Head of Operations, Sentien Biotechnologies Inc.
                  • Camilo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis - Co-Founder & CEO, Aegis BioDefense Inc., USA
                  9:10am - 10:00am50 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  PANEL: COVID-19: Trailblazers in the CGT Industry
                  • Chris Gemmiti, Ph.D. - Head of Operations, Sentien Biotechnologies Inc.
                  • Camilo Ricordi - Stacy Joy Goodman Professor of Surgery and Chief, Division of Cellular Transplantation, Distinguished Professor of Medicine, Professor of Biomedical Engineering, Microbiology and Immunology, Director, Diabetes Research Institute and Cell Transplant Center, University of Miami, Fellow, National Academy of Inventors, USA, Member, Italian Supreme Council of Health, USA
                  • Racheli Ofir - Vice President Research & Intellectual Property, Pluristem Therapeutics Inc., Israel
                  • John Lewis - Co-Founder & CEO, Aegis BioDefense Inc., USA
                  10:00am - 11:00am60 mins
                  Cell Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Bayer
                  • Walter Kowtonuik - Principal, Third Rock Ventures, USA
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  Gene Edited Ex Vivo Cell Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Bayer
                  • Walter Kowtonuik - Principal, Third Rock Ventures, USA
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  In Vivo Gene Therapy
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Bayer
                  • Walter Kowtonuik - Principal, Third Rock Ventures, USA
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  10:00am - 11:00am60 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  PANEL: Investment in the CGT space: trends, technologies and early stage success
                  • Mike Zhao - Senior Vice President, MSQ Ventures
                  • Jak Knowles - VP Venture Investments, Bayer
                  • Walter Kowtonuik - Principal, Third Rock Ventures, USA
                  • Joey Mason - Head of the Life Sciences Fund, M Ventures, The Netherlands
                  • Dominic Schmidt - Partner, Syncona Investment Management Ltd., UK
                  11:00am - 11:30am30 mins
                  Cell Therapy
                  Spotlight Presentation
                    11:00am - 11:30am30 mins
                    Gene Edited Ex Vivo Cell Therapy
                    Spotlight Presentation
                      11:00am - 11:30am30 mins
                      In Vivo Gene Therapy
                      Spotlight Presentation
                        11:00am - 11:30am30 mins
                        Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                        Spotlight Presentation
                          11:30am - 11:50am20 mins
                          Cell Therapy
                          Risk-Based Approaches for Autologous CAR T-Cell Therapy Comparability
                          • Erica Bust - Senior Process Engineer, Juno Therapeutics Inc., USA
                          11:30am - 11:50am20 mins
                          Gene Edited Ex Vivo Cell Therapy
                          Encapsulation Approaches – A Case study from Sigilon
                          • Martha Rook - SVP, Manufacturing, Sigilon Therapeutics Inc.
                          11:30am - 11:50am20 mins
                          In Vivo Gene Therapy
                          Assessing the Future Prospects of Upstream Bioprocessing Systems for Commercial AAV Production
                          • Scott Jeffers - Director, UniQure
                          11:30am - 11:50am20 mins
                          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                          Optimization of Cell Culture and Differentiation
                          • Jan Jensen - CEO and Founder, Trailhead Biosystems Inc.
                          11:50am - 12:15pm25 mins
                          Cell Therapy
                          Speaker Q&A - Process Development Considerations & Strategies
                          • Jon A. Rowley, Ph.D. - Founder & Chief Product Officer, RoosterBio Inc.
                          • Margarida Serra - Head of Stem Cell Bioengineering Lab, iBET - Instituto de Biologia Experimental e Tecnológica
                          • Erica Bust - Senior Process Engineer, Juno Therapeutics Inc., USA
                          11:50am - 12:15pm25 mins
                          Gene Edited Ex Vivo Cell Therapy
                          Speaker Q&A - Auto vs. Allo Manufacturing & Infrastructure
                          • Ali Mohamed - VP, CMC, Immatics, USA
                          • Shyam Patel - Director Business Development, California Institute for Regenerative Medicine
                          • Martha Rook - SVP, Manufacturing, Sigilon Therapeutics Inc.
                          • Vadim Klyushnichenko - VP Pharmaceutical Development and Quality, Calibr at Scripps Research
                          11:50am - 12:15pm25 mins
                          In Vivo Gene Therapy
                          Speaker Q&A - High Throughput Applications in Production Platforms & Enabling Manufacturing Tech
                          • Scott Jeffers - Director, UniQure
                          • Sha Sha - Postdoc, Massachusetts Institute of Technology
                          11:50am - 12:15pm25 mins
                          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                          Unique Methods for Cell Harvest
                          • Jason Walsh - Chief Financial Officer, GPB SCIENTIFIC, LLC
                          12:15pm - 1:00pm45 mins
                          Cell Therapy
                          Networking Reception
                            12:15pm - 1:00pm45 mins
                            Gene Edited Ex Vivo Cell Therapy
                            Networking Reception
                              12:15pm - 1:00pm45 mins
                              In Vivo Gene Therapy
                              Networking Reception
                                12:15pm - 1:00pm45 mins
                                Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                                Networking Reception
                                  WATCH ON DEMAND
                                  NextDAY TWO WATCH LIVE (EST); 20/10/20

                                  Get the latest news.
                                  As it happens

                                  Sign up to get the latest on the agenda and speakers.
                                  Filter
                                  Streams
                                  Choose Day